Rafferty Asset Management
STOK icon

Rafferty Asset Management’s Stoke Therapeutics STOK Stock Holding History

Rafferty Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Sell
59,898
-30,295
-34% -$994K 0.01% 619
2025
Q4 		$2.86M Buy
90,193
+54,866
+155% +$1.65M 0.01% 572
2025
Q3 		$830K Sell
35,327
-16,131
-31% -$276K ﹤0.01% 832
2025
Q2 		$584K Sell
51,458
-10,248
-17% -$97.3K ﹤0.01% 853
2025
Q1 		$410K Sell
61,706
-5,521
-8% -$51.5K ﹤0.01% 908
2024
Q4 		$742K Sell
67,227
-15,561
-19% -$191K ﹤0.01% 840
2024
Q3 		$1.02M Buy
82,788
+2,903
+4% +$41.1K ﹤0.01% 796
2024
Q2 		$1.08M Buy
+79,885
New +$1.08M ﹤0.01% 806
2023
Q1 		– Sell
-14,429
Closed -$133K – 1165
2022
Q4 		$133K Buy
14,429
+3,382
+31% +$35.2K ﹤0.01% 1099
2022
Q3 		$142K Buy
+11,047
New +$176K ﹤0.01% 1110
2022
Q2 		– Sell
-62,065
Closed -$1.31M – 1219
2022
Q1 		$1.31M Buy
62,065
+15,624
+34% +$313K 0.01% 727
2021
Q4 		$1.11M Buy
46,441
+13,926
+43% +$332K 0.01% 821
2021
Q3 		$827K Sell
32,515
-278
-0.8% -$7.75K 0.01% 913
2021
Q2 		$1.1M Sell
32,793
-2,027
-6% -$71.7K 0.01% 847
2021
Q1 		$1.35M Buy
+34,820
New +$1.98M 0.01% 703

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Rafferty Asset Management's STOK Position: Q1 2026 in Review

Rafferty Asset Management reduced its Stoke Therapeutics (STOK) stake by 34% in Q1 2026, selling an estimated $994K and leaving 59,898 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #619.

Rafferty Asset Management first reported a position in STOK in Q1 2021 and has held it in 15 quarters since. The position peaked at $2.86M in Q4 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Rafferty Asset Management held 59,898 shares of Stoke Therapeutics worth $1.95M as of Q1 2026.
  • Rafferty Asset Management sold 30,295 Stoke Therapeutics shares in Q1 2026, an estimated $994K.
  • Stoke Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #619 holding.
  • Rafferty Asset Management first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 15 quarters since.
  • Rafferty Asset Management's Stoke Therapeutics position peaked at $2.86M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.